Recipharm

We're hiring! Recipharm is looking for a Head of Corporate QMS to lead the development and implementation of quality processes across our global network, ensuring regulatory compliance and continuous improvement.   Read more and apply now! https://lnkd.in/dzJtcfYj     #QualityManagement #PharmaCareers #Leadership #Recipharm

With our unique platform ReciPredict we solve complex problems in product development, tech-transfer, and routine manufacturing in an efficient and reliable way. ReciPredict optimises pharmaceutical development, tech-transfer and life cycle management by merging the Recipharm expertise with state-of-the-art material sciences, process sciences, and data sciences with small scale, pilot scale and full scale GMP equipment into an integrated platform. In our latest factsheet we explain how you can accelerate your project timeline, reduce API consumption and fully understand your materials and processes with our unique platform. Intrigued? Read our latest factsheet: https://lnkd.in/d9UXYshP #TechTransfer #Pharmadevelopment #OSD #FillFinish

Exciting opportunity at Recipharm in the Greater Munich Area! We are looking for a Finance Director to join our Senior Leadership Team and drive strategic financial growth in a leading sterile manufacturing facility. Apply now! https://lnkd.in/d36TSaZx    #FinanceJobs #PharmaCareers #Leadership #Recipharm

CASE STUDY | Discover how we collaborated with Innoviva Specialty Therapeutics and ACS Dobfar to overcome the complexities of developing and launching a new antibiotic, addressing scientific and market challenges. The partnership, which focused on integrated support and efficient scale-up from clinical to commercial production, resulted in the FDA approval of the antibiotic after six years. A critical imperative of the collaboration was simultaneously achieving the highest quality standards and navigating the constraints of tight project deadlines. Read the full case study here: https://lnkd.in/dWE83Veu #antibiotics #CDMO #fillfinish

ReciBioPharm is at the 12th International mRNA Health Conference in Boston! Don’t miss the chance to connect with their team at Booth 18 and explore the latest in xRNA manufacturing and development. #CDMO #mRNA #biotech

🌍 On International Coastal Cleanup Day, the Recipharm team in Lisbon came together to make a positive impact! Close to 40 colleagues and their families gathered at Praia da Rainha, Costa da Caparica, to help clean the beach. With guidance from the Blue Flag Association, we collected 35 kg of rubbish, showing that small actions can lead to big change. Proud of our team for making a difference! #CDMO #Sustainability #Recipharm 

ReciPredict- Value By Design In our latest interview series Dr. Uwe Hanenberg, Head of Product Implementation at Recipharm explains the unique capabilities of ReciPredict. What sets it apart? It brings a comprehensive suite of tools into one cohesive platform. With ReciPredict we have the resources to fully characterize your material, assessing attributes like flowability, particle size, density, and other essential factors. Additionally, ReciPredict includes essential software and statistical tools, enabling precise analysis and the extraction of meaningful insights from this data. But the strength lies not just in technology—it’s also about the scientific experts at Recipharm. We understand your product’s complexities, and by harnessing our approach and expertise, we provide the clarity you need to take the next steps toward success. Learn more about ReciPredict : https://lnkd.in/dHyEyaUi #QbD #Drugdevelopment #TechTransfer #OSD

We're ready to meet your sterile fill and finish needs, now and in the future! With a global footprint and specialist infrastructure, we support pharmaceutical companies worldwide. Our local experts offer tailored regulatory guidance for all target markets. Backed by a strong regulatory track record, our state-of-the-art facilities ensure seamless filling, tech transfer, and the supply of varied and continuously growing doses. Whether for small or large molecules, including vaccines, our global network and local experts are here to solve your fill and finish challenges. Learn more about our Sterile fill & Finish offering here: https://lnkd.in/dTWJ7aAx #CDMO #Fillfinish #Vaccine #PFS

Recipharm is your partner through every phase of development, we have experts and capabilities to work with you from API route scouting and synthesis to commercial manufacturing. Whether you're navigating early- or late-stage development or need clinical supply, we're here to ensure seamless progress and high-quality results. What you can expect: NPI support: Efficient product development and tech-transfer ReciPredict: Integrated toolkit that enables data-driven and informed decisions Extensive lab capabilities: Advanced labs and analytical services for reliable results GMP pilot-scale equipment: Flexible capabilities to refine and develop your product Blockbuster manufacturing lines: High-capacity lines, ready for your commercial success We offer scalable capacity and state-of-the-art capabilities tailored to protect and maximize your product's potential—no matter the size or complexity of your project. Let’s discuss how we can support your journey to success! https://lnkd.in/dY3bBZkD #CDMO #ProcessDevelopment #TechTransfer #OSD #FillFinish

In a podcast interview with PharmaSource during CPHI, Jon Reed, Head of Strategic Business Planning at Recipharm, discusses the evolving trends in the pharmaceutical space and how we are addressing our clients' pain points: • Speed to market: With the recent launch of ReciPredict, we can reduce time to market by 3-6 months. • Need for smaller scale production and personalised medicin: We are extending our capabilities with smaller-scale, flexible production lines. • GLP-1 and blockbuster drugs: With large-scale equipment, we can respond to emerging requirements from the industry in both sterile filling and the manufacturing of oral solid dosage forms. Listen to the full podcast to learn more about what the future of pharma looks like: https://lnkd.in/d52VThWY